Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Recombinant factor-viia

Renal thromboembolism: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Milosevic D, et al. Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors. BMC Pediatrics 14: No. 315, 17 Dec 2014. Available from: URL: http://doi.org/10.1186/s12887-014-0315-2 - Croatia Milosevic D, et al. Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors. BMC Pediatrics 14: No. 315, 17 Dec 2014. Available from: URL: http://​doi.​org/​10.​1186/​s12887-014-0315-2 - Croatia
Metadaten
Titel
Recombinant factor-viia
Renal thromboembolism: case report
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-0046-7

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Zolmitriptan

Case report

BCG vaccine

Case report

Levobupivacaine

Case report

Risperidone